Probabilistic noncancer risk estimation

Comments on Toxicology

Volumn 7, Issue 5-6, 2001, Pages 541-574

  Baird, Sandra J S ^a   Slob, Wout ^b   Jarabek, Annie M ^c  

^a Menzie Cura and Associates   (United States)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Animal to human extrapolation; Bayesian methods; Benchmark dose; Dose response; Human heterogeneity; Reference concentration; Reference dose; Uncertainty; Variability

Indexed keywords

EID: 0005961830     PISSN: 08865140     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. S.J.S. Baird, J.T. Cohen, J.D. Graham, A.I. Shlyakhter, and J.S. Evans, Human Ecol. Risk Assess. 2, 79 (1996).
2. A. J. Lehman, and O. G. Fitzhugh, Assoc. Food Drug Off. U. S. Q. Bull. 18, 33 (1954).
3. W. Slob and M.N. Pieters, Risk Anal. 18, 787 (1998).
4. P.J. Catalano, D.O. Scharfstein, L.M. Ryan, C.A. Kimmel, and G.L. Kimmel, Teratol. 47, 281 (1993).
5. W. Pease, J. Vandenberg and K. Hooper, Environ. Health Perspec. 91, 141 (1991).
6. D. Hattis, P. Banati, and R. Goble, Annals NY Acad. Sci., 895, 286 (1999).
7. P.S. Price, R.E. Keenan, J.C. Swartout, C.A. Gillis, H. Carlson-Lynch and M.L. Dourson, Risk Anal., 17, 427 (1997).
8. E.J. Calabrese, Regul. Toxicol. Pharmacol. 5, 190 (1985).
9. D.J., Guth, R.C. Hertzberg, and A.M. Jarabek, Fund. Appl. Toxicol. 20, 1-14. (1993).
10. J.C. Swartout, P.S. Price, M.L. Dourson, H.L. Carlson-Lynch and R.E. Keenan, Risk Anal., 18, 271 (1998).
11. T. Vermeire, H. Stevenson, M.N. Pieters, M. Rennen, W. Slob, and B.C. Hakkert, Crit. Rev. Toxicol. 29, 439 (1999).
12. S.C. Lewis, J.R. Lynch and A.I. Nikiforov, Regul. Toxicol. Pharmacol. 11, 314 (1990).
13. B.D. Beck, R.B. Connolly, M.L. Dourson, D. Guth, D. Hattis, C. Kimmel, and S.C. Lewis, Fund. and Appl. Toxicol. 20, (1993).
14. D.W. Gaylor and R.L. Kodell, Risk Anal., 20, 245 (2000).
15. A.M. Jarabek and V. Hasselblad, Human and Ecol. Risk Assess. (Accepted, 1999).
16. V. Hasselblad and A.M. Jarabek, Applied Bayesian Methods for Biostatisticians (D.A. Berry and D.K. Stangl, eds., Marcel Dekker, NY, 1996).
17. W. Slob, Risk Anal. 14, 571 (1994).
18. J.S. Evans, L.R. Rhomberg, P.L. Williams, A.M. Wilson and S.J.S. Baird, Risk Anal., (accepted).
19. K.S. Crump, Fund. Appl. Toxicol. 4, 854 (1984).
20. D. G. Barnes, G.P. Daston, J.S. Evans, A.M. Jarabek, R.J. Kavlock, C.A. Kimmel, C. Park and H.L. Spitzer, Regul. Toxicol. Pharmacol. 21, 296 (1994).
21. USEPA. The use of the benchmark dose approach in health risk assessment. RAF, ORD, EPA/630/R-94-007 (1995).
22. USEPA. Draft revisions to the guidelines for carcinogen risk assessment. ORD, OHEA, EPA report no. EPA/600/BP-92/003 (1994).
23. W. Slob and M.N. Pieters, RIVM, Report No. 620110 006 (1997).
24. B. Hoadley, J. Am. Stat. Assoc. 65, 356 (1970).
25. J. P. Buonaccorsi and C.A. Gatsonis, Biometrics. 44, 87 (1988).
26. D.M. Eddy, V. Hasselblad and R.D Shachter, The Statistical Synthesis of Evidence: Meta Analysis by the Confidence Profile Method (Academic Press, 1992).
27. J.O. Berger, Statistical Decision Theory and Bayesian Analysis, (Second Ed., Springer-Verlag, New York, 1985).
28. K. Crump and R. Howe, Toxicological Risk Assessment, (Krewski, D., ed., CRC Press, Canada, 1985).
29. J. O. Berger, and R.L. Wolpert, Lecture Notes -Monograph Series Volume 6, (S. S. Gupta, ed., Institute of Mathematical Statistics, Hayward, CA, 1984).
30. E.A. Anderson, P.F. Diesler, Jr., D. McCallum, C. St. Hilaire, H.L. Spitzer, H. Strauss, J.D. Wilson, and R. Zimmerman, Risk Anal. 13, 379 (1993).
31. W.H. DuMouchel, and J.E. Harris, J. Am. Stat. Assoc. 78, 293 (1983).
32. S.J.S. Baird, G.M. Gray, J.T. Cohen, and L. Rhomberg, presented at Society for Risk Analysis Annual Meeting (1997).
33. L.R. Rhomberg, S.J.S. Baird, G.M. Gray, J.S. Evans and J.T. Cohen, Framing for development of data-derived probability distributions in workshops of experts, prepared for Health Canada (1997).
34. A.M. Jarabek, Human and Ecol. Risk Assess. 1, 641 (1995).
35. US EPA Federal Register, 57(109), 24152 (1992).
36. USEPA, Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry, EPA/600/8-90/066F (1994).
37. S.J.S. Baird, J.S. Evans, L.R. Rhomberg, P.L. Williams and A.M. Wilson, Ethylene oxide developmental and reproductive toxicity risk assessment: Application of a probabilistic noncancerrisk assessment methodology, prepared for American Chemistry Council (2000).
38. L.R. Rhomberg and S.K. Wolff, Risk Anal., 18, 741 (1998).
39. C.W. Schmidt, C.A. Gillis, R.E. Keenan, and P.S. Price, Fund. Appl. Tox., Suppl.-The Toxicologist, 36(1, Part 2), 208 (1997).
40. A.M. Jarabek, Inhal. Toxicol. 7, 927 (1995).
41. H.J. Clewell, J.M. Gearhart, P. R. Gentry, T.R. Covington, C.B. VanLandingham, K.S. Crump and A.M. Shipp, Risk Anal. 19, 547 (1999).
42. A.G. Renwick and N.R. Lazarus, Reg. Tox. and Pharm., 27, 3 (1998).
43. A.M. Jarabek and V. Hasselblad, presentation at ILSI (1999).
44. M.L. Dourson and J.F. Stara, Reg. Tox. and Pharm., 3, 224 (1983).
45. C.S. Weil, C.P. Carpenter, J.S. West and H.F. Smyth, Jr., Am. Industrial Hyg. Assoc. J. 27, 483 (1966).
46. C.S. Nessel, S.C. Lewis, K.L. Stauber and J.L. Adgate, Human and Ecol. Risk Assess. 1, 516 (1995).
47. H.J. Kramer, W.A. van den Ham, W. Slob and M.N. Pieters, Regul. Toxicol. Pharmacol. 23, 249 (1996).
48. J.C. Swartout, Fund. Appl. Tox., Suppl.- The Toxicologist 36, 209 (1997).
49. W.A. Mitchell, J.S. Gift, C.K. Webb and A.M. Jarabek, Fund. Appl. Tox., Suppl.-The Toxicologist 13, 140 (1993).
50. M.L. Dourson, L.A. Knauf and J.C. Swartout, Toxicol. Indus. Health, 8, 171 (1992).
51. J.S. Evans and S.J.S. Baird, Human Ecol. Risk Assess. 4, 291 (1998).
52. M.S. Bogdanffy and A.M. Jarabek, Toxicol. Lett. 82/83, 919 (1995).
53. D.W. Gaylor, Regul. Toxicol. Pharmacol. 15, 151 (1992).
54. US EPA, Federal Register 56(234), 63798 (1991).
55. W. Leisenring and L. Ryan, Regul. Toxicol. Pharmacol. 15, 161 (1992).
56. K.P. Brand, L. Rhomberg and J.S. Evans, Risk Anal. 19, 295 (1999).
57. L.T. Haber, B.C. Allen and C.A. Kimmel, Toxicol. Sci. 43, 213 (1999).
58. M. Ballew and D. Hattis, Report from: Center for Technology Policy and Industrial Development at the Massachusetts Institute of Technology, CTPID 87-1 (1987).
59. R. Heywood, Toxicol. Let. 8, 349 (1981).
60. R. Heywood, Toxicol. Let. 18, 83 (1983).
61. J.S. Evans, G.M. Gray, R.L. Sielken, Jr., A.E. Smith, C. Valdez-Flores and J.D. Graham, Regul. Toxicol. Pharmacol. 20, 15 (1994).
62. E.M. Faustman, B.C. Allen, R.J. Kavlock and C.A. Kimmel, Fund. Appl. Toxicol. 23, 478 (1994).
63. B.C. Allen, R.J. Kavlock, C.A. Kimmel and E.M. Faustman, Fund. Appl. Toxicol. 23, 487 (1994).
64. B.C. Allen, R.J. Kavlock, C.A. Kimmel and E.M. Faustman, Fund. Appl. Toxicol. 23, 496 (1994).
65. D.G. Barnes and M. Dourson, Regul. Toxicol. Pharmacol. 8, 471 (1988).